Academic literature on the topic 'Rabies virus vectors'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rabies virus vectors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Rabies virus vectors"

1

Mori, Takuma, and Edward M. Callaway. "Recombinant rabies virus vectors." Neuroscience Research 65 (January 2009): S72. http://dx.doi.org/10.1016/j.neures.2009.09.249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Xiang, Z. Q., G. P. Gao, A. Reyes-Sandoval, Y. Li, J. M. Wilson, and H. C. J. Ertl. "Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier." Journal of Virology 77, no. 20 (2003): 10780–89. http://dx.doi.org/10.1128/jvi.77.20.10780-10789.2003.

Full text
Abstract:
ABSTRACT E1 deletion adenoviral vectors of the human serotype 5 (AdHu5) and the chimpanzee serotype 68 (AdC68) expressing the rabies virus glycoprotein (rab.gp) were tested for induction of transgene product-specific antibodies upon intranasal or oral immunization of newborn mice. Both vectors induced antibodies to rabies virus that could be detected in serum and mucosal secretions. Serum rabies virus-neutralizing antibody titers sufficed to protect neonatally vaccinated mice against a subsequent challenge with rabies virus. The efficacy of the AdHu5rab.gp vector given orally to newborn mice b
APA, Harvard, Vancouver, ISO, and other styles
3

GILBERT A., T. "Rabies virus vectors and reservoir species." Revue Scientifique et Technique de l'OIE 37, no. 2 (2018): 371–84. http://dx.doi.org/10.20506/rst.37.2.2808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

BLANCOU, J., and A. WANDELER. "Rabies virus and its vectors in Europe." Revue Scientifique et Technique de l'OIE 8, no. 4 (1989): 927–29. http://dx.doi.org/10.20506/rst.8.4.467.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gomme, Emily A., Elizabeth J. Faul, Phyllis Flomenberg, James P. McGettigan, and Matthias J. Schnell. "Characterization of a Single-Cycle Rabies Virus-Based Vaccine Vector." Journal of Virology 84, no. 6 (2010): 2820–31. http://dx.doi.org/10.1128/jvi.01870-09.

Full text
Abstract:
ABSTRACT Recombinant rabies virus (RV)-based vectors have demonstrated their efficacy in generating long-term, antigen-specific immune responses in murine and monkey models. However, replication-competent viral vectors pose significant safety concerns due to vector pathogenicity. RV pathogenicity is largely attributed to its glycoprotein (RV-G), which facilitates the attachment and entry of RV into host cells. We have developed a live, single-cycle RV by deletion of the G gene from an RV vaccine vector expressing HIV-1 Gag (SPBN-ΔG-Gag). Passage of SPBN-ΔG-Gag on cells stably expressing RV-G a
APA, Harvard, Vancouver, ISO, and other styles
6

Osakada, Fumitaka, and Edward M. Callaway. "Design and generation of recombinant rabies virus vectors." Nature Protocols 8, no. 8 (2013): 1583–601. http://dx.doi.org/10.1038/nprot.2013.094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ohara, Shinya, Ken-ichi Inoue, Masahiro Yamada, Ken-Ichiro Tsutsui, and Toshio Iijima. "Dual viral transneuronal tracing using recombinant rabies virus vectors." Neuroscience Research 58 (January 2007): S242. http://dx.doi.org/10.1016/j.neures.2007.06.596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kurup, Drishya, Christoph Wirblich, Heinz Feldmann, Andrea Marzi, and Matthias J. Schnell. "Rhabdovirus-Based Vaccine Platforms against Henipaviruses." Journal of Virology 89, no. 1 (2014): 144–54. http://dx.doi.org/10.1128/jvi.02308-14.

Full text
Abstract:
ABSTRACTThe emerging zoonotic pathogens Hendra virus (HeV) and Nipah virus (NiV) are in the genusHenipavirusin the familyParamyxoviridae. HeV and NiV infections can be highly fatal to humans and livestock. The goal of this study was to develop candidate vaccines against henipaviruses utilizing two well-established rhabdoviral vaccine vector platforms, recombinant rabies virus (RABV) and recombinant vesicular stomatitis virus (VSV), expressing either the codon-optimized or the wild-type (wt) HeV glycoprotein (G) gene. The RABV vector expressing the codon-optimized HeV G showed a 2- to 3-fold in
APA, Harvard, Vancouver, ISO, and other styles
9

Antunes, K. D., J. C. C. Matos, L. P. Mol, et al. "Descriptive analysis of rabies in wild animals in the state of Sergipe, Brazil." Arquivo Brasileiro de Medicina Veterinária e Zootecnia 70, no. 1 (2018): 169–73. http://dx.doi.org/10.1590/1678-4162-9574.

Full text
Abstract:
ABSTRACT The wild cycle of rabies constitutes a serious challenge to epidemiological surveillance for disease control in domestic, companion or production animals, and in humans. The understanding of rabies virus circulation in the natural environment is increasingly important due to the constancy of natural reservoirs of the disease and the presence of potential vectors of the infection to humans and domestic animals. Aiming to evaluate the occurrence of rabies in the State of Sergipe a total of 935 hematophagous bats (Desmodus rotundus), 46 wild dogs (Cerdocyon thous) and 24 primates (Callit
APA, Harvard, Vancouver, ISO, and other styles
10

Srithayakumar, Vythegi, Hariharan Sribalachandran, Rick Rosatte, Susan A. Nadin-Davis, and Christopher J. Kyle. "Innate immune responses in raccoons after raccoon rabies virus infection." Journal of General Virology 95, no. 1 (2014): 16–25. http://dx.doi.org/10.1099/vir.0.053942-0.

Full text
Abstract:
Zoonotic wildlife diseases pose significant health risks not only to their primary vectors but also to humans and domestic animals. Rabies is a lethal encephalitis caused by rabies virus (RV). This RNA virus can infect a range of terrestrial mammals but each viral variant persists in a particular reservoir host. Active management of these host vectors is needed to minimize the negative impacts of this disease, and an understanding of the immune response to RV infection aids strategies for host vaccination. Current knowledge of immune responses to RV infection comes primarily from rodent models
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Rabies virus vectors"

1

Tanabe, Soshi. "Developing novel techniques for primate neural network analyses by retrograde gene transfer with viral vectors." Kyoto University, 2020. http://hdl.handle.net/2433/253133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lauer, Katharina. "A multipathogen vaccine for rabies, hepatitis B, Japanese encephalitis and enterovirus 71." Thesis, University of Manchester, 2016. https://www.research.manchester.ac.uk/portal/en/theses/a-multipathogen-vaccine-for-rabies-hepatitis-b-japanese-encephalitis-and-enterovirus-71(f489f961-317e-4430-becc-0474cae79268).html.

Full text
Abstract:
To enhance the global control of encephalitis and hepatitis caused by rabies virus (RABV), Japanese encephalitis virus (JEV), enterovirus 71 (EV71) and hepatitis B virus (HBV), novel immunisation strategies are needed. All four diseases particularly affect low income countries with marginal health services – an affordable combined vaccine strategy could alleviate the large burden of disease. Therefore, we aimed to construct a multipathogen vaccine assessing the immunising activity of a recombinant modified vaccinia Ankara (MVA), expressing key antigens (RABV-glycoprotein, JEV pre-membrane & en
APA, Harvard, Vancouver, ISO, and other styles
3

Aspden, Kate. "A study of the host-restricted lumpy skin disease virus as a vaccine vector using rabies babies virus as a model." Doctoral thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/2740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mota, Tiago José Abreu. "Development of a Lassa/Rabies virus vaccine based on the rabies vector." Doctoral thesis, 2019. http://hdl.handle.net/1822/66881.

Full text
Abstract:
Tese de Doutoramento em Medicina<br>Lassa fever (LF), is a viral hemorrhagic fever caused by Lassa virus (LASV), for which neither an approved vaccine or effective treatment is available. LASV is an endemic virus in western Africa and a major health and economic burden, causing an estimate 100,000-300,000 infections yearly, with the number of reported infections increasing in the last years. This thesis describes the development of LASSARAB, a dual LF and rabies vaccine based on recombinant rabies vector. Rabies is another equally important disease in Africa that is estimated to cause th
APA, Harvard, Vancouver, ISO, and other styles
5

Svobodová, Barbora. "Znalosti žáků středních škol v oblasti vybraných zoonóz." Master's thesis, 2016. http://www.nusl.cz/ntk/nusl-354085.

Full text
Abstract:
The subject of the dissertation deals with the secondary school pupil's awareness of zoonoses. Zoonoses are the diseases transmited from animals to human beings. Those are one of the topics of biology study currently. The main aim of the dissertation is theoretical definition of the matter in the first place. For knowledge testing have been chosen these four illness: Toxoplasmosis, Lyme boreliossis, Rabies and Creuzfeldt-Jakobo disease. With these chosen illness the main research goal is to provide a comprehensive collection of information about the details such as disease transfer, spread of
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Rabies virus vectors"

1

Conzelmann, Karl-Klaus. "Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm." In Sendai Virus Vector. Springer Japan, 2013. http://dx.doi.org/10.1007/978-4-431-54556-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lathe, Richard, and Marie Paule Kieny. "The Early Development of the Vaccinia–Rabies Recombinant Vaccine Raboral®." In Rabies Virus [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.97344.

Full text
Abstract:
The recombinant vaccinia–rabies vaccine, now known as Raboral®, has been widely used in Europe and North America to control/eliminate rabies in the principal wildlife vectors, and thus prevent human transmission. The origins of this vaccine are sometimes forgotten, although the formulation has not changed substantially in almost four decades. This groundbreaking vaccine was assembled by a team at a very young (at that time) genetic engineering company, Transgène, in Strasbourg, France. The joint leaders of the rabies vaccine team reflect, 36 years later, on the trials and tribulations that went hand in hand with the construction of the vaccine.
APA, Harvard, Vancouver, ISO, and other styles
3

Warrell, Mary J., and David A. Warrell. "Rhabdoviruses: Rabies and rabies-related lyssaviruses." In Oxford Textbook of Medicine, edited by Christopher P. Conlon. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0085.

Full text
Abstract:
The Rhabdoviridae are a large family of RNA viruses, two genera of which infect animals: the genus Lyssavirus contains rabies and rabies-related viruses that cause at least 55,000 deaths annually in Asia and Africa. The risks and problems posed by rabies and other lyssaviruses vary across the world. Viruses can penetrate broken skin and intact mucosae. Humans are usually infected when virus-laden saliva is inoculated through the skin by the bite of a rabid animal, usually a dog. Although the greatest threat to man is the persistent cycle of infection in stray dogs, several other terrestrial mammal species are reservoirs of infection. In the Americas, bat viruses and also classic type 1 rabies and insectivorous bats have become the principal vectors of infection to humans in the United States of America. Elsewhere in the world, there is increasing evidence of widespread rabies-related lyssavirus infection of bats.
APA, Harvard, Vancouver, ISO, and other styles
4

Gomme, Emily A., Celestine N. Wanjalla, Christoph Wirblich, and Matthias J. Schnell. "Rabies Virus as a Research Tool and Viral Vaccine Vector." In Advances in Virus Research. Elsevier, 2011. http://dx.doi.org/10.1016/b978-0-12-387040-7.00009-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sanz, Marta Gonzalez, and Caoimhe Nic Fhogartaigh. "Zoonotic Infections." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0046.

Full text
Abstract:
The term zoonosis comes from the Greek: ζῷον (zoon) ‘animal’ and νόσος (nosos) ‘sickness’, and means an infection transmissible from animals to humans. Infected animals can be symptomatic or asymptomatic, and humans usually become accidental hosts through close contact with the reservoir animal. Six out of ten infections in humans globally are spread from animals, and 75% of emerging infections are zoonotic. Some occur worldwide e.g. E. coli O157:H7, whereas some are more restricted geographically, e.g. Ebola virus. The highest burden is in developing countries. There are various classifications of zoonoses. ● Causative pathogen: bacterial (anthrax, non-typhoidal Salmonelloses); viral (rabies, Yellow Fever, hantaviruses); parasitic (hookworm, Giardia, toxoplasmosis); fungal (dermatophytes, histoplasmosis); or prion (new-variant Creutzfeldt-Jakob disease). ● Mode of transmission (see Section 35.3 and Table 35.1 below) ● Distribution: endemic zoonoses are continually present in a population (e.g. leptospirosis, brucellosis); epidemic zoonoses occur intermittently (e.g. anthrax, Rift Valley Fever); emerging zoonoses are new infections, or existing infections that are increasing in incidence or geographical range (e.g. Nipah virus, Middle East Respiratory Syndrome coronavirus). ● Direct contact: infectious particles are present on an infected animal, in its body fluids, and in its excreta. Q fever, caused by Coxiella burnetii, and brucellosis may be acquired by direct contact with infected animals, particularly during parturition; cat-scratch disease caused by Bartonella henselae, and Pasteurella spp. may be acquired by bites or scratches from cats, and rabies from canine bites. Many zoonoses are also transmitted via indirect animal contact through exposure to soil or water contaminated by infectious material, e.g. leptospirosis may be acquired when water contaminated with infected rats’ urine comes into contact with broken skin or mucous membranes. ● Ingestion: infection occurs by ingesting contaminated food or water, e.g. unpasteurized milk, poorly processed or undercooked meat, or by eating/ drinking after handling animals without handwashing. Listeria, bovine tuberculosis, and brucellosis may be transmitted by unpasteurized milk and dairy produce; Hepatitis E through processed pork, and Ebola and Marburg through bushmeat. ● Vector-borne: infection is transmitted through a biting arthropod vector. Examples include West Nile Virus and Japanese encephalitis from mosquitoes, Lyme disease, tick-borne encephalitis, and Rocky Mountain Spotted Fever from ticks, and Rickettsia typhi from rat fleas.
APA, Harvard, Vancouver, ISO, and other styles
6

William Tong, C. Y. "Different Types of Vaccines." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0061.

Full text
Abstract:
Vaccines can be classified according to their nature into the following types: ● Inactivated vaccines: ■ Whole organism; ■ Acellular extracts. ● Live attenuated vaccines. ● Toxoid vaccines. ● Subunit vaccines. ● Conjugate vaccines. ● DNA vaccines. ● Recombinant vector vaccines. Inactivation of the whole organism is the most basic form of vaccine produced by killing the micro-organism causing the disease using heat, chemical or radiation and presents all the antigens in the inactivated organism as a vaccine to induce immunity in the recipient. Other methods to produce an inactivated vaccine is by extracting acellular components of the organism through filtration. Examples of inactivated bacterial vaccines currently in use include: ● Anthrax—sterile filtrate from cultures of the Sterne strain of B. anthracis. ● Cholera—oral inactivated vaccine with 1mg of recombinant cholera toxin B (rCTB) in a liquid suspension of four strains of killed V. cholerae O1, representing subtypes Inaba and Ogawa and biotypes El Tor and classical. ● Pertussis—acellular vaccine has replaced previously used whole cell vaccine. ● Typhoid—purified Vi capsular polysaccharide from S. typhi; NB: the injectable, killed, whole-cell typhoid vaccine which contains heat-inactivated, phenol-preserved S. typhi organisms is no longer in use in the UK. Examples of inactivated viral vaccines currently in use in the UK include: ● Hepatitis A virus. ● Hepatitis E virus. ● Influenza A and B viruses. ● Japanese encephalitis virus. ● Polio viruses 1, 2, and 3 (IPV). ● Rabies virus. ● Tick-borne encephalitis virus. ● Bacterial vaccines: Bacillus Calmette-Guerin (BCG) vaccine is a live attenuated vaccine against tuberculosis derived from a Mycobacterium bovis strain. The oral typhoid vaccine contains a live attenuated strain of S. typhi (Ty21a) in an enteric-coated capsule. ● Viral vaccines: The measles, mumps, and rubella (MMR) vaccine contain live attenuated strains of measles, mumps, and rubella viruses, which are cultured separately and mixed before being lyophilized. Oral polio vaccine (OPV) against polio viruses 1, 2, and 3—OPV contains live attenuated strains of poliomyelitis virus types 1, 2, and 3 grown in cell cultures.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!